A Glimpse Into The Expert Outlook On Autolus Therapeutics Through 5 Analysts
A Glimpse Into The Expert Outlook On Autolus Therapeutics Through 5 Analysts
通过5位分析师的专家观点一窥autolus therapeutics
Analysts' ratings for Autolus Therapeutics (NASDAQ:AUTL) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
根据5位分析师的表示，Autolus Therapeutics（NASDAQ：AUTL）过去一季度的分析师评级从看好变成看淡不等。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天内情绪的变化，并将它们与前几个月进行比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $9.4, a high estimate of $11.00, and a low estimate of $9.00. This current average reflects an increase of 1.62% from the previous average price target of $9.25.
分析师分析12个月的目标价格，提供有用的信息，平均目标价格为9.4美元，最高估价为11.00美元，最低估价为9.00美元。目前的平均目标价格反映了1.62％的增长自上一个平均目标价格9.25美元。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细剖析
In examining recent analyst actions, we gain insights into...
通过对最近的分析师...
登录免费看全文
登录/注册